SynthesisFrontiers in oncology2024

Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis.

Bowen Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.